Early Antiretroviral Therapy in Resource Limited Settings in Patients With High CD4+ Cell Counts.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antiretrovirals; Efavirenz; Emtricitabine/tenofovir disoproxil fumarate; Lopinavir/ritonavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms EARLI; NIH-EARLI
- 04 Mar 2016 Biomarkers information updated
- 10 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Nov 2011 New trial record